Biotechnology Pilot Plant


Personal information


Name:

Jonathan Stanway

Service Provider:

GlaxoSmithKline

Date:

Wednesday, November 8, 2017


Type of Collaboration:

Fee paying basis, Funded collaborative project, Negotiable


What 'non-technical' services relevant to scale-up does your organisation offer?:

Life Cycle Assessment, Process Modelling, Technoeconomic Assessment

Asset Information


Asset Information: 
Biotechnology Pilot Plant
Raw Material: 
Biomass - any
Process Stage: 
Primary Processing
Technology Area: 
Industrial biotechnology
Technology: 
Industrial fermentation
Scale: 
Semi Pilot, Pilot, Demonstration
Size: 
10 - 99 L, 100 - 999 L, 1000 - 99999 L
Capacity: 
1 - 9 KG/H
10 - 99 KG/H
Additional technical information: 

Microbial fermentation capability @ 1L, 10L, 100L, 1000L & 4000L available (100-4000L capability is mothballed but available for use) with batch and continuous media sterilisation.
Further capability in seed preparation and banking, cell harvest, homogenisation, membrane filtration, solvent extraction, distillation, enzyme immobilisation and product recovery.

Contact Information: 
Southdownview Way
Worthing
West Sussex
BN14 8QH
United Kingdom
Southdownview Way, Worthing, West Sussex BN14 8QH, United Kingdom
Service Provider: 
GlaxoSmithKline

This project has received funding from the Bio Based Industries Joint Undertaking under the European Union’s 'Horizon 2020 Research and Innovation Programme', under Grant Agreement No 730052